What was recalled
The U.S. Consumer Product Safety Commission has issued a recall for specific batches of TriDerma Pain Relief Cream, a topical anesthetic product designed to provide temporary relief from minor aches and pains. This action covers two distinct packaging formats that share the same hazardous labeling issue: the 4-ounce jar and the 2.2-ounce tube. If you have used this brand for muscle soreness or joint pain in the past, it is important to verify whether your specific container is part of this alert, as the recall is limited to particular lot numbers and expiration dates rather than the entire product line indefinitely.
The affected 4-ounce jar is visually identifiable by its white container paired with a white dome cap. The label features a distinctive design with lime green and pink printed elements that clearly display the brand name "TriDerma Pain Relief Cream." Alongside the jar, the recall also encompasses the 2.2-ounce tube version of the cream. This tube shares the same visual branding, featuring a white body with the same lime green and pink printed label. Because the packaging design is consistent across both formats, consumers should rely on the lot numbers to determine if their item is included in this specific recall notice.
To confirm if your product is affected, you must check the lot number and expiration date printed on the packaging. For the jar, these details are located on the bottom of the container. For the tube, look for the lot number and expiration date on the front of the crimped end. The specific lot numbers currently subject to this recall are 21088, 20189, 0738F02A, 0738F04A, 0738F04B, 0738F04C, 0739A22A, 0739A22B, and 0739A23A. The corresponding expiration dates for these lots range from April 2021 to January 2022. If your product falls within this date range and matches one of the listed lot numbers, it is part of the recall.
This recall was officially announced on April 25, 2019. At the time of the announcement, the CPSC noted that TriDerma was actively contacting all known purchasers directly to inform them of the issue. The company has stated that they are providing free replacement child-resistant caps to consumers who contact them. For those who purchased this product during or after the recall date, it is advisable to check your purchase records if you are unsure whether you were contacted. If you have any of the affected items in your home, please stop using them immediately and follow the remedy instructions provided by TriDerma to ensure your safety and that of your family.
The hazard, explained
At the heart of this TriDerma recall is a seemingly minor packaging oversight that creates a significant safety gap for households with young children. The core issue is that the containers for these pain relief creams failed to meet the rigorous standards set by the Poison Prevention Packaging Act (PPPA). This federal law, enforced by the Consumer Product Safety Commission (CPSC), requires certain hazardous household substances to be packaged in containers that are difficult for children under five years old to open, yet not unduly difficult for adults to use. The TriDerma products in question—specifically the 4-ounce jars and 2.2-ounce tubes of Pain Relief Cream—were equipped with standard caps rather than the specialized child-resistant closures mandated for this type of product. Consequently, the physical barrier that is supposed to prevent a curious toddler from accessing the contents simply does not exist.
The danger lies in what is inside those containers. This cream contains 4% lidocaine, a topical anesthetic that works by blocking nerve signals in the body to reduce pain and itching. While effective for adults when used as directed, lidocaine becomes highly toxic if ingested or absorbed through the skin in large amounts by a small child. Because children have much lower body weight than adults, even a small quantity of this medication can lead to an overdose. The mechanism of harm is straightforward: without a child-resistant cap, a young child can easily twist open the jar or squeeze the tube. If they then put their fingers in their mouth after touching the cream, or directly ingest the substance, the lidocaine enters their system rapidly.
Lidocaine poisoning is particularly serious because it affects the central nervous system and the heart. Symptoms of ingestion can include dizziness, confusion, vomiting, and irregular heartbeat. In severe cases, it can lead to seizures, respiratory failure, or even death. The risk is compounded by the fact that young children are naturally curious and may not understand that a cream intended for pain relief is dangerous if eaten. They might mistake the product for food due to its packaging appearance or simply because they do not know better. This recall highlights how critical proper packaging is; it serves as the first line of defense against accidental poisoning. Without the required child-resistant closure, the product relies entirely on parental vigilance, which, while important, is not a reliable substitute for physical safety features designed to keep hazardous substances out of reach. The absence of these caps means that any lapse in supervision could result in immediate and potentially life-threatening exposure.
Who is most at risk
When we discuss product safety recalls, it is easy to view the statistics as abstract numbers on a government spreadsheet. However, behind every recall alert are real people whose daily routines and health needs intersect with a potential hazard. In this specific case involving TriDerma Pain Relief Cream, the primary group at risk consists of households where young children live or visit frequently. The core issue here is not just that the cream exists, but that its packaging failed to meet the strict child-resistant standards mandated by the Poison Prevention Packaging Act. This means that a container designed to be secure for adults may open too easily for small hands, allowing access to a substance that can be dangerous if misused.
Lidocaine is a topical anesthetic commonly used to numb minor skin irritations, cuts, or insect bites. While it is generally safe when used as directed by older children and adults, it poses a significant threat to toddlers and infants. Young children are naturally curious and explore the world through touch and taste. If they gain access to this jar or tube, they might mistake the cream for a snack or a harmless lotion. Because their bodies are much smaller than those of adults, even a small amount of lidocaine absorbed through the skin or ingested can lead to systemic poisoning. The symptoms of such poisoning can range from dizziness and nausea to more severe effects like seizures or difficulty breathing, which require immediate medical attention.
Beyond young children, other vulnerable groups include individuals with cognitive impairments or those who may have difficulty reading labels clearly. Elderly users, who might be the primary purchasers of this pain relief cream for managing arthritis or muscle aches, often share their living spaces with grandchildren. A caregiver might assume that placing the jar on a bathroom counter is safe because it is out of immediate reach, but without a proper child-resistant cap, a climbing toddler can still access it. Furthermore, anyone who stores medication in common areas rather than locked cabinets relies entirely on the packaging’s integrity to keep their family safe.
It is also important to note that risk is not limited to those who own the product. Visitors to homes where TriDerma Pain Relief Cream is kept are equally vulnerable if the packaging does not prevent unauthorized access. Since the recall announcement notes that no incidents have been reported yet, this is a proactive measure by the Consumer Product Safety Commission (CPSC) and TriDerma to prevent harm before it occurs. The absence of current reports should not be interpreted as a sign that the product is safe for children; rather, it highlights the importance of vigilance. Parents, grandparents, and caregivers must recognize that the lack of a child-resistant closure transforms a simple pain relief product into a potential hazard in any home with accessible storage.
Ultimately, the people most at risk are those who cannot understand the danger of the substance or physically cannot open a standard container but can easily manipulate this specific flawed packaging. By understanding who is vulnerable, you can take immediate steps to secure your home environment and ensure that no one is exposed to the risks associated with non-compliant pharmaceutical packaging.
How to tell if you have the recalled item
Before taking any action, it is essential to confirm whether your TriDerma Pain Relief Cream is part of this specific recall. The U.S. Consumer Product Safety Commission (CPSC) issued this alert on April 25, 2019, targeting products that failed to meet federal child-resistant closure requirements. Because the packaging looks very similar to standard, safe containers, you need to look closely at several specific details to ensure you are dealing with the affected units. The recall covers two distinct formats of the product: a jar and a tube, both containing 4% Lidocaine. If your cream is in a bottle or spray canister, it is not part of this recall.
Start by examining the container's physical appearance. For the jar version, you are looking for a white container with a white dome cap. The label on the jar features a distinctive design with lime green and pink printed elements. The brand name "TriDerma Pain Relief Cream" should be clearly visible on the front of the jar. If you have the tube version, it will also be white with the same lime green and pink printed label. However, the tube does not have a dome cap; instead, you will see a crimped end where the product is sealed. It is crucial to verify that the label explicitly states "TriDerma Pain Relief Cream," as other pain relief creams may look similar but are not subject to this specific safety alert.
The most definitive way to identify the recalled items is by checking the lot numbers and expiration dates, which are printed directly on the packaging. For the 4-ounce jar, these details are located on the bottom of the container. If you have the 2.2-ounce tube, look at the front of the crimped end. You must compare these codes against the specific list provided by TriDerma. The affected lot numbers and their corresponding expiration dates are as follows: Lot 21088 (Exp. 04/2021), Lot 20189 (Exp. 04/2021), Lot 0738F02A (Exp. 06/2021), Lot 0738F04A (Exp. 06/2021), Lot 0738F04B (Exp. 06/2021), Lot 0738F04C (Exp. 06/2021), Lot 0739A22A (Exp. 01/2022), Lot 0739A22B (Exp. 01/2022), and Lot 0739A23A (Exp. 01/2022). If your product bears any of these lot numbers, it is part of the recall. If the lot number does not appear on this list, or if the expiration date differs significantly from those listed above, your product is likely not affected by this specific safety issue.
If you are unsure about the origin of the cream or cannot find the lot number, do not guess. Contact TriDerma directly for assistance. You can reach their customer service team at 800-279-7282 between 7 a.m. and 4:30 p.m. PT, Monday through Friday, or via email at marilyn@triderma.com. They can help you verify whether your specific batch is included in the recall.
What to do — step by step
If you have purchased TriDerma Pain Relief Cream, your immediate priority is ensuring that the product is not accessible to young children. The core issue with this recall is not that the cream itself is harmful when used correctly, but rather that the packaging fails to meet the strict safety standards required by law for products containing potentially dangerous chemicals. Because the lidocaine in this cream poses a risk of poisoning if ingested or absorbed in large amounts by a child, your first and most critical step is to immediately remove the jar or tube from any area where children might find it. Do not leave it on bathroom counters, nightstands, or in medicine cabinets that are unlocked or within reach. Instead, store the product in a secure location out of sight and out of reach of children, such as a locked drawer or a high shelf inside a closed cabinet. This temporary measure is vital because it breaks the chain of access before you can resolve the packaging defect.
Once the product is safely stored, you should not attempt to use it yourself until the recall is resolved, nor should you throw it away yet, as you will need proof of purchase or the specific lot information for the replacement process. Your next step is to contact TriDerma directly to arrange for a free replacement child-resistant cap. The company has committed to contacting all known purchasers, but taking proactive action ensures you receive your remedy promptly. You can reach their customer service team by calling 800-279-7282. It is important to note that their support hours are from 7 a.m. to 4:30 p.m. Pacific Time, Monday through Friday, so plan your call accordingly if you are in a different time zone. Alternatively, you may send an email to marilyn@triderma.com or visit their website at www.triderma.com and navigate to the Customer Service section for more detailed information on how to proceed.
When you contact TriDerma, have your product ready to provide the lot number and expiration date. These details are printed on the bottom of the jar or on the front of the crimped end of the tube. Providing this specific information will help the company verify that your item is part of the affected batch and expedite the shipment of the replacement cap. Once you receive the new child-resistant cap, carefully attach it to your container according to the instructions provided. This simple mechanical fix restores the safety barrier that was missing from the original packaging. By following these steps—securing the product, contacting the manufacturer, and installing the correct closure—you effectively eliminate the risk of accidental poisoning while retaining a product that is otherwise safe for its intended adult use.
Your refund, repair, or replacement options
If you have determined that your TriDerma Pain Relief Cream is part of this recall, the good news is that the manufacturer has established a straightforward and cost-free remedy to resolve the issue. Because the core problem involves a safety defect in the packaging rather than the efficacy or quality of the cream itself, the primary solution offered is not a cash refund, but rather a free replacement child-resistant cap. This approach is designed to be quick and convenient for you, ensuring that your product becomes safe to use without requiring you to dispose of the medication entirely.
To obtain this safety upgrade, you need to contact TriDerma directly. The company has set up specific channels for consumers to request their complimentary caps. You can reach them by phone at 800-279-7282. Their customer service team is available from 7 a.m. to 4:30 p.m. Pacific Time, Monday through Friday. If you prefer written communication or need more detailed instructions, you may also email them directly at marilyn@triderma.com. Alternatively, you can visit their official website at www.triderma.com and navigate to the Customer Service section for online support options. It is important to use only these official contact methods to ensure your request is processed correctly and securely.
While you wait for your replacement cap to arrive, or if you choose not to wait, there are immediate steps you must take to protect your household. The recall notice explicitly advises that you should immediately store the topical anesthetic in a safe location that is completely out of reach of children. This is a critical interim measure because, until you receive the new child-resistant cap, the current packaging does not meet federal safety standards for preventing accidental access by young kids. Do not leave the jar or tube on bathroom counters, nightstands, or in any place where a curious child might find it.
TripDerna is also taking proactive steps to manage this recall. They are contacting all known purchasers directly to inform them of the issue and coordinate the distribution of the replacement caps. This means that if you purchased the product recently through their direct channels, you may hear from them without needing to initiate the contact yourself. However, it is best practice to reach out proactively if you have not heard from them within a reasonable timeframe, as this ensures your specific lot number is accounted for in their records. There are no reported conditions or fees associated with receiving the replacement cap; it is provided free of charge as part of their commitment to consumer safety.
If you are unable to obtain a replacement cap, or if you simply prefer not to keep the product, your alternative option is to dispose of the cream safely. While the recall notice focuses on the provision of the new cap, standard safety practice for any medication with a compromised container is to ensure it cannot be accessed by anyone in your home. You can mix the cream with an unpalatable substance like coffee grounds or cat litter in a sealed bag before throwing it away, or check with local pharmacies for drug take-back programs. However, given that a free and effective solution (the new cap) is available, replacing the closure is generally the most practical and environmentally friendly option.
Remember, the goal of this remedy is to maintain the safety of your home while allowing you to continue using the product if you wish. Lidocaine is a powerful topical anesthetic, and while it is effective for pain relief, it poses a serious poisoning risk if ingested or absorbed in large quantities by children. By securing the child-resistant cap, you eliminate that specific risk. The process is designed to be hassle-free, so please do not hesitate to use the phone number or email address provided to get your safe packaging quickly.
What can happen if you ignore it
It is completely understandable why you might want to keep using this product. TriDerma Pain Relief Cream is designed to help manage discomfort, and throwing away a partially used jar or tube feels like a waste of money. However, the core issue here is not about the cream’s effectiveness; it is about the safety of its container. The recall exists because the packaging fails to meet the strict child-resistant closure requirements mandated by the Poison Prevention Packaging Act. This means that while the cap looks secure to an adult, it does not pose a sufficient barrier for young children who are naturally curious and developing their fine motor skills.
If you ignore this recall and leave the product within reach, you are exposing young children to a significant risk of poisoning. The cream contains 4% lidocaine, which is a local anesthetic that numbs nerve endings. While this is helpful for pain relief in adults, it can be dangerous if ingested or absorbed through the skin in large amounts by a small child. A child does not need to swallow the entire jar to suffer serious effects. Even a small amount can lead to toxic levels of lidocaine in their system.
The consequences of such exposure can range from mild symptoms like nausea, vomiting, and drowsiness to more severe and life-threatening conditions. In cases of significant ingestion or absorption, children may experience seizures, irregular heartbeat, difficulty breathing, or loss of consciousness. Because children’s bodies are smaller and their metabolic systems are still developing, they process chemicals differently than adults, making them far more vulnerable to adverse reactions from the same dose that might be harmless to you.
Although the CPSC has not reported any specific incidents or injuries at this time, the absence of reported cases does not mean the risk is zero. It simply means that no one has yet come forward with a story of harm. Relying on luck is never a prudent safety strategy. The potential outcome of ignoring this warning is a medical emergency that could have been easily prevented by simply storing the product in a locked cabinet or contacting TriDerma for their free replacement cap. By acting now, you ensure that your home remains a safe place for your children to explore without the hidden danger of accessible toxic substances.
- Poisoning Risk: Lidocaine can cause serious neurological and cardiac issues in children if ingested.
- Unintended Access: Non-child-resistant caps are easily opened by toddlers, who may mistake the cream for food or candy.
- Medical Emergency: Severe reactions can require immediate hospitalization and intensive care.
Staying safe: broader tips
While this specific recall addresses a packaging failure for TriDerma Pain Relief Cream, the underlying principle is universal: keeping potent topical medications out of reach is one of the most effective ways to prevent accidental poisoning in households with young children. Lidocaine and similar topical anesthetics are not merely irritants; they are active drugs that can be absorbed through the skin or cause serious systemic toxicity if ingested. Because children are naturally curious and often explore their environment by putting objects in their mouths, any container that resembles food packaging or is easily accessible becomes a significant risk. General safety experts emphasize that "child-resistant" does not mean "child-proof." No cap is impenetrable to a determined toddler, which is why storage location is just as critical as the closure mechanism itself.
To significantly reduce the risk of accidental exposure to household medications, consider implementing a multi-layered safety strategy. First, establish a "high and hard-to-reach" rule for all medicines, whether they are in prescription bottles, over-the-counter jars, or tubes. A high shelf in a bathroom cabinet or a closet is ideal, but ensure that the items are not stored on the very top edge where they might be pulled down. Second, always replace the original safety caps immediately after use. It can be tempting to swap a medicine into a decorative jar or a reused food container for convenience, but this practice drastically increases the danger of confusion and ingestion. Never transfer medications to unlabeled containers, as this removes the critical warning labels that alert family members and emergency responders to the contents.
Beyond storage habits, regular household audits can prevent many accidents. Periodically check all medicine cabinets and drawers, especially those in bathrooms and kitchens, to ensure that lids are secure and that no items have expired or been left out after use. If you have multiple caregivers, such as grandparents or babysitters, have a clear conversation about medication safety protocols. Ensure they understand that "safe" means locked away or stored in a high cabinet, not just tucked into the back of an open drawer. Additionally, keep the number for your local poison control center prominently displayed in your phone and on your refrigerator. In the United States, this is 1-800-222-1222. Knowing who to call and having that information readily available can save precious minutes during a crisis.
Finally, stay informed about product safety by regularly checking official recall databases like those maintained by the Consumer Product Safety Commission (CPSC). Recalls are not just for dangerous toys; they frequently involve everyday items like creams, supplements, and household cleaners. Subscribing to recall alerts or periodically visiting these government resources ensures you are aware of potential hazards before they affect your family. By combining vigilant storage practices with up-to-date safety knowledge, you create a robust defense against accidental injuries, ensuring that your home remains a safe haven for everyone.